1. |
Mayo SC, Pawlik TM. Current management of colorectal hepatic metastasis. Expert Rev Gastroenterol Hepatol, 2009, 3(2): 131-144.
|
2. |
Chua TC, Liauw W, Chu F, et al. Viewing metastatic colorectal cancer as a curable chronic disease. Am J Clin Oncol, 2012, 35(1): 77-80.
|
3. |
Ungureanu BS, Sandulescu L, Surlin V. Surgical hepatic resection vs. ultrasonographic guided radiofrequency ablation in colorectal liver metastases: what should we choose? Med Ultrason, 2014, 16(2): 145-151.
|
4. |
Stillwell AP, Buettner PG, Ho YH. Meta-analysis of survival of patients with stageⅣcolorectal cancer managed with surgical resec-tion versus chemotherapy alone. World J Surg, 2010, 34(4): 797-807.
|
5. |
Jegatheeswaran S, Mason JM, Hancock HC, et al. The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review. JAMA Surg, 2013, 148(4): 385-391.
|
6. |
Ammori JB, D'Angelica MI, Fong Y, et al. Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metas-tases and extrahepatic disease. J Surg Oncol, 2012, 106(8): 953-958.
|
7. |
Kanas GP, Taylor A, Primrose JN, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of progno-stic factors. Clin Epidemiol, 2012, 4: 283-301.
|
8. |
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 2010, 17(6): 1471-1474.
|
9. |
Adson MA, Van Heerden JA. Major hepatic resections for metastatic colorectal cancer. Ann Surg, 1980, 191(5): 576-583.
|
10. |
2014 NCCN Guideline Updates: Experts Highlight New Recommen-dations for Clinical Practice.http://www.onclive.com/publications/obtn/2014/may-2014/2014-nccn-guideline-updates-experts-highlight-new-recommendations-for-clinical-practice.
|
11. |
Yin Z, Liu C, Chen Y, et al. Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): Simultaneous or delayed? Hepatology, 2013, 57(6): 2346-2357.
|
12. |
Mayo SC, Pulitano C, Marques H. Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis. J Am Coll Surg, 2013, 216(4): 707-716.
|
13. |
Jones RP, Jackson R, Dunne DF, et al. Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metas-tases. Br J Surg, 2012, 99(4): 477-486.
|
14. |
Kingham TP, D'Angelica M, Kemeny NE. Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metas-tases. J Surg Oncol, 2010, 102(8): 988-995.
|
15. |
Ye LC, Liu TS, Ren L, et al. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. J Clin Oncol, 2013, 31(16): 1931-1938.
|
16. |
Pozzo C, Basso M, Cassano A, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol, 2004, 15(6): 933-939.
|
17. |
Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg, 2004, 240(4): 644-657; discussion 657-648.
|
18. |
Adam R, Hoti E, Folprecht G, et al. Accomplishments in 2008 in the management of curable metastatic colorectal cancer. Gastrointest Cancer Res, 2009, 3(5 Supplement 2): S15-S22.
|
19. |
Imamura H, Seyama Y, Kokudo N, et al. Single and multiple resec-tions of multiple hepatic metastases of colorectal origin. Surgery, 2004, 135(5): 508-517.
|
20. |
Folprecht G, Grothey A, Alberts S, et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol, 2005, 16(8): 1311-1319.
|
21. |
Yoo PS, Lopez-Soler RI, Longo WE, et al. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab. Clin Colorectal Cancer, 2006, 6(3): 202-207.
|
22. |
Altendorf-Hofmann A, Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am, 2003, 12(1): 165-192.
|
23. |
Adam R, de Haas RJ, Wicherts DA, et al. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol, 2008, 26(22): 3672-3680..
|
24. |
Marin C, Robles R, Lopez Conesa A, et al. Outcome of strict patient selection for surgical treatment of hepatic and pulmonary metastases from colorectal cancer. Dis Colon Rectum, 2013, 56(1): 43-50.
|
25. |
Pulitano C, Bodingbauer M, Aldrighetti L, et al. Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol, 2011, 18: 1380-1388.
|
26. |
Carpizo DR, Are C, Jarnagin W, et al. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Oncol, 2009, 16(8): 2138-2146.
|
27. |
Carpizo DR, D'Angelica M. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Ann Surg Oncol, 2009, 16(9): 2411-2421.
|